Form 8-K - Current report:
SEC Accession No. 0001213900-25-033946
Filing Date
2025-04-22
Accepted
2025-04-22 08:20:41
Documents
19
Period of Report
2025-04-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0238925-8k_cerotherap.htm   iXBRL 8-K 62912
2 FORM OF CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF THE ea023892501ex3-1_cerotherap.htm EX-3.1 297583
3 SECURITIES PURCHASE AGREEMENT, DATED AS OF APRIL 21, 2025, BY AND BETWEEN CERO T ea023892501ex10-1_cerotherap.htm EX-10.1 333821
4 FORM OF REGISTRATION RIGHTS AGREEMENT BY AND BETWEEN CERO THERAPEUTICS HOLDINGS, ea023892501ex10-2_cerotherap.htm EX-10.2 171571
5 FORM OF CONSENT AGREEMENT ea023892501ex10-3_cerotherap.htm EX-10.3 24383
6 PRESS RELEASE OF CERO THERAPEUTICS HOLDINGS, INC., DATED APRIL 22, 2025 ea023892501ex99-1_cerotherap.htm EX-99.1 9282
  Complete submission text file 0001213900-25-033946.txt   1345212

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE cero-20250421.xsd EX-101.SCH 3797
8 XBRL DEFINITION FILE cero-20250421_def.xml EX-101.DEF 26672
9 XBRL LABEL FILE cero-20250421_lab.xml EX-101.LAB 36816
10 XBRL PRESENTATION FILE cero-20250421_pre.xml EX-101.PRE 25296
21 EXTRACTED XBRL INSTANCE DOCUMENT ea0238925-8k_cerotherap_htm.xml XML 5942
Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376
CERO THERAPEUTICS HOLDINGS, INC. (Filer) CIK: 0001870404 (see all company filings)

EIN.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40877 | Film No.: 25855275
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)